What is the ticker symbol for Neoleukin Therapeutics?

Neoleukin Therapeutics trades under the ticker NLTX on NASDAQ.

What sector does Neoleukin Therapeutics operate in?

Neoleukin Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze NLTX in a portfolio?

PortView shows NLTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Neoleukin Therapeutics (NLTX) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$3.49+1.45%

1-year price historyRange $2.12 – $4.63

52-week range$3.49

$3.42$18.80

What Neoleukin Therapeutics does

Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.

Key metrics

Market cap

$8.20M

P/E (TTM)

-0.28

EPS (TTM)

$-12.28

Beta

1.10

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$13.83

200-day avg

$14.98

52-week high

$18.80

52-week low

$3.42

CEO

Donna M. Cochener-Metcalfe

ETFs linked to NLTX

Broad-market and Healthcare sector ETFs an investor holding Neoleukin Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NLTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NLTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Neoleukin Therapeutics?: Neoleukin Therapeutics trades under the ticker NLTX on NASDAQ.
Which exchange is NLTX listed on?: NLTX is listed on NASDAQ.
What sector does Neoleukin Therapeutics operate in?: Neoleukin Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze NLTX in a portfolio?: PortView shows NLTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.